| Cyclopia: An epidemiologic study in a large dataset from the International Clearinghouse of Birth Defects Surveillance and Research |
|
|
|
|
|
|
|
|
|
| Very rare defects: What can we learn? |
|
|
|
|
|
|
✓ |
✓ |
Amerindian ethnicity |
| Cloacal exstrophy: An epidemiologic study from the International Clearinghouse for Birth Defects Surveillance and Research |
|
|
|
|
|
|
|
|
|
| Amelia: A multi‐center descriptive epidemiologic study in a large dataset from the International Clearinghouse for Birth Defects Surveillance and Research, and overview of the literature |
|
|
|
|
|
|
|
|
|
| Bladder exstrophy: An epidemiologic study from the International Clearinghouse for Birth Defects Surveillance and Research, and an overview of the literature |
|
|
|
|
|
|
|
|
|
| Sirenomelia: An epidemiologic study in a large dataset from the International Clearinghouse of Birth Defects Surveillance and Research, and literature review |
|
|
|
|
|
|
|
|
|
| Conjoined twins: A worldwide collaborative epidemiological study of the International Clearinghouse for Birth Defects Surveillance and Research |
|
|
|
|
|
|
✓ |
✓ |
ethnicity; South American countries |
| Editorial comment: Foreword to very rare defects: What can we learn? |
|
|
|
|
|
|
|
|
|
| Acardia: Epidemiologic findings and literature review from the International Clearinghouse for Birth Defects Surveillance and Research |
|
|
|
|
|
|
|
|
|
| Phocomelia: A worldwide descriptive epidemiologic study in a large series of cases from the International Clearinghouse for Birth Defects Surveillance and Research, and overview of the literature |
|
|
|
|
|
|
|
|
|
| How do we know if an exposure is actually teratogenic in humans? |
|
|
|
|
|
|
|
|
|
| Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: Modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States |
|
|
|
|
|
|
|
|
|
| Genetic basis of susceptibility to teratogen induced birth defects |
|
|
|
|
|
|
|
|
|
| Monitoring for teratogenic signals: Pregnancy registries and surveillance methods |
|
|
|
|
|
|
|
|
|
| Emerging issues in teratology: An introduction |
|
|
|
|
|
|
|
|
|
| The art and science of teratogen risk communication |
|
|
|
|
|
|
|
|
|
| Teratogenic exposures |
|
|
|
|
|
|
|
|
|
| The importance of dysmorphology in the identification of new human teratogens |
|
|
|
|
|
|
|
|
|
| Laboratory models and their role in assessing teratogenesis |
|
|
|
|
|
|
|
|
|
| Case–control studies for identifying novel teratogens |
|
|
|
|
|
|
|
|
|
| We don't know what we don't study: The case for research on medication effects in pregnancy |
|
|
|
|
|
|
|
|
|
| Evolving knowledge of the teratogenicity of medications in human pregnancy |
|
|
|
|
|
|
|
|
|
| The role of teratology information services in screening for teratogenic exposures: Challenges and opportunities |
|
|
|
|
|
|
|
|
|
| Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes |
|
|
|
|
|
|
|
|
|
| Observations on intelligence and behavior in 15 patients with Legius syndrome |
|
|
|
|
|
|
|
|
|
| Skeletal muscle pathology in Costello and cardio‐facio‐cutaneous syndromes: Developmental consequences of germline Ras/MAPK activation on myogenesis |
|
|
|
|
|
|
|
|
|
| Disorders of the Ras pathway: An introduction |
|
|
|
|
|
|
|
|
|
| The musculoskeletal phenotype of the RASopathies |
|
|
|
|
|
|
|
|
|
| Neurocognitive, adaptive, and behavioral functioning of individuals with Costello syndrome: A review |
|
|
|
|
|
|
|
|
|
| Costello and cardio‐facio‐cutaneous syndromes: Moving toward clinical trials in RASopathies |
|
|
|
|
|
|
|
|
|
| Cardio‐facio‐cutaneous syndrome: Does genotype predict phenotype? |
|
|
|
|
|
|
|
|
|
| Hypermethioninemias of genetic and non‐genetic origin: A review |
|
|
|
|
|
|
✓ |
✓ |
Asian countries |
| Lysinuric protein intolerance: Reviewing concepts on a multisystem disease |
|
|
|
|
|
|
|
|
|
| Disorders of creatine transport and metabolism |
|
|
|
|
|
|
|
|
|
| Argininosuccinate lyase deficiency—Argininosuccinic aciduria and beyond |
|
|
|
|
|
|
|
|
|
| Newborn screening and inborn errors of metabolism |
|
|
|
|
|
|
|
|
|
| Newborn screening for lysosomal storage disorders |
|
|
|
|
|
|
|
|
|
| Inborn errors of cobalamin absorption and metabolism |
|
|
|
|
|
|
|
|
|